Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer - PubMed (original) (raw)
Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer
Michael P Keane et al. J Immunol. 2004.
Abstract
The Glu-Leu-Arg(+) (ELR(+)) CXC chemokines are potent promoters of angiogenesis and have been demonstrated to induce a significant portion of nonsmall cell lung cancer-derived angiogenic activity and support tumorigenesis. ELR(+) CXC chemokines share a common chemokine receptor, CXCR2. We hypothesized that CXCR2 mediates the proangiogenic effects of ELR(+) CXC chemokines during tumorigenesis. To test this postulate, we used syngeneic murine Lewis lung cancer (LLC; 3LL, H-2(b)) heterotopic and orthotopic tumor model systems in C57BL/6 mice replete (CXCR2(+/+)) and deficient in CXCR2 (CXCR2(-/-)). We first demonstrated a correlation of the expression of endogenous ELR(+) CXC chemokines with tumor growth and metastatic potential of LLC tumors. Next, we found that LLC primary tumors were significantly reduced in growth in CXCR2(-/-) mice. Moreover, we found a marked reduction in the spontaneous metastases of heterotopic tumors to the lungs of CXCR2(-/-) mice. Morphometric analysis of the primary tumors in CXCR2(-/-) mice demonstrated increased necrosis and reduced vascular density. These findings were further confirmed in CXCR2(+/+) mice using specific neutralizing Abs to CXCR2. The results of these studies support the notion that CXCR2 mediates the angiogenic activity of ELR(+) CXC chemokines in a preclinical model of lung cancer.
Similar articles
- The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM. Addison CL, et al. J Immunol. 2000 Nov 1;165(9):5269-77. doi: 10.4049/jimmunol.165.9.5269. J Immunol. 2000. PMID: 11046061 - CXCR2 is critical to hyperoxia-induced lung injury.
Sue RD, Belperio JA, Burdick MD, Murray LA, Xue YY, Dy MC, Kwon JJ, Keane MP, Strieter RM. Sue RD, et al. J Immunol. 2004 Mar 15;172(6):3860-8. doi: 10.4049/jimmunol.172.6.3860. J Immunol. 2004. PMID: 15004193 - The chemokine receptor, CXCR2, mediates the tumorigenic effects of ELR+ CXC chemokines.
Keane MP, Burdick MD, Xue YY, Lutz M, Belperio JA, Strieter RM. Keane MP, et al. Chest. 2004 May;125(5 Suppl):133S. doi: 10.1378/chest.125.5_suppl.133s. Chest. 2004. PMID: 15136463 No abstract available. - CXC chemokines in angiogenesis relevant to chronic fibroproliferation.
Strieter RM, Belperio JA, Burdick MD, Keane MP. Strieter RM, et al. Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):23-6. doi: 10.2174/1568010053622902. Curr Drug Targets Inflamm Allergy. 2005. PMID: 15720231 Review. - Role of C-X-C chemokines as regulators of angiogenesis in lung cancer.
Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL. Strieter RM, et al. J Leukoc Biol. 1995 May;57(5):752-62. doi: 10.1002/jlb.57.5.752. J Leukoc Biol. 1995. PMID: 7539029 Review.
Cited by
- Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy.
Jung H, Paust S. Jung H, et al. Front Immunol. 2024 Jul 16;15:1443366. doi: 10.3389/fimmu.2024.1443366. eCollection 2024. Front Immunol. 2024. PMID: 39114657 Free PMC article. Review. - Immune Cell Migration to Cancer.
Ryan AT, Kim M, Lim K. Ryan AT, et al. Cells. 2024 May 16;13(10):844. doi: 10.3390/cells13100844. Cells. 2024. PMID: 38786066 Free PMC article. Review. - The role and metabolic adaptations of neutrophils in premetastatic niches.
Chen E, Yu J. Chen E, et al. Biomark Res. 2023 May 9;11(1):50. doi: 10.1186/s40364-023-00493-6. Biomark Res. 2023. PMID: 37158964 Free PMC article. Review. - The Role of CXC Chemokines in Cancer Progression.
Wu T, Yang W, Sun A, Wei Z, Lin Q. Wu T, et al. Cancers (Basel). 2022 Dec 28;15(1):167. doi: 10.3390/cancers15010167. Cancers (Basel). 2022. PMID: 36612163 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- CA87879/CA/NCI NIH HHS/United States
- HL03906/HL/NHLBI NIH HHS/United States
- HL04493/HL/NHLBI NIH HHS/United States
- HL66027/HL/NHLBI NIH HHS/United States
- P50CA90388/CA/NCI NIH HHS/United States
- P50HL67665/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials